Deleuran, Mette, Danielle Marcoux, Marjolein S. De Bruin-Weller, Alan D. Irvine, Eulalia Baselga, Kangmo Ahn, Ana Paula Castro, Ashish Bansal, Jingdong Chao, Gaëlle Bégo-Le-Bagousse, and Ana B. Rossi. “Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents With Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use”. Acta Dermato-Venereologica 101, no. 7 (July 15, 2021): adv00504. Accessed May 2, 2024. https://medicaljournalssweden.se/actadv/article/view/133.